Escuchar el podcast Flot.bio x Philip Hemme

Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics \| Christian Angermayer \| E61	Flot.bio x Philip Hemme	74:40
ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech \| Pierre d’Epenoux \| E60	Flot.bio x Philip Hemme	47:24
CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River \| E59 [Sponsored]	Flot.bio x Philip Hemme	61:30
Ex-CEO of Incyte Hervé Hoppenot on 10x Growth, Biotech Cycles, and Breaking Bureaucracy \| E58	Flot.bio x Philip Hemme	58:35
Christoph Lengauer, Curie.Bio \| Biotech Founders, Venture Capital \| E57	Flot.bio x Philip Hemme	79:16
Sander Slootweg, Forbion 🇳🇱 \| European Biotech Investment, Venture Capital \| E56	Flot.bio x Philip Hemme	66:42
Solving Antimicrobial Resistance, Vaccines, Antibiotics \| Immunethep 🇵🇹 \| E55 [Sponsored]	Flot.bio x Philip Hemme	62:50
António Portela, Bial 🇵🇹 \| Parkinson’s, Family-Owned Biotech \| E54	Flot.bio x Philip Hemme	31:23
Claus Crone Fuglsang, Novonesis 🇩🇰 \| Biosolutions, Industrial biotech, Synbio \| E53	Flot.bio x Philip Hemme	70:31
Sten R. Sörensen, Cereno Scientific 🇸🇪 \| Drug Repurposing, Retail Investors \| E52 [Sponsored]	Flot.bio x Philip Hemme	84:41
Fredrik Tiberg, Camurus 🇸🇪 \| Opioid Crisis, Long-Acting Injections \| E51	Flot.bio x Philip Hemme	60:42
Alessandro Riva, Transgene \| Cancer Vaccines, Oncolytic Viruses \| E50	Flot.bio x Philip Hemme	65:36
Pascal Touchon 🇫🇷 \| Cell Therapy, Jeito, Kymriah \| E49	Flot.bio x Philip Hemme	74:33
Werner Lanthaler 🇦🇹 \| Biopharma AI, CDMO, Antibody Optimization \| E48	Flot.bio x Philip Hemme	59:34
Thomas Lingelbach, Valneva \| Vaccines, Lyme Disease \| E47	Flot.bio x Philip Hemme	44:27
Marc de Garidel, Abivax 🇫🇷 \| Ulcerative Colitis, Inflammation \| E46	Flot.bio x Philip Hemme	53:40
Laurent Levy, Nanobiotix 🇫🇷 \| Nanoparticles, Radiotherapy \| E45	Flot.bio x Philip Hemme	50:03
Gerrit Sitters, LUMICKS 🇳🇱 \| CAR-T therapy, Single-Cell Analysis \| E44 [Sponsored]	Flot.bio x Philip Hemme	84:33
Fabrice Chouraqui, Pharming 🇳🇱 \| Transgenic Rabbits, Rare Diseases \| E43	Flot.bio x Philip Hemme	54:48
Daniela Marino, CUTISS 🇨🇭 \| Tissue Engineering, Skin Grafts \| E42 [Sponsored]	Flot.bio x Philip Hemme	67:40
Dragan Grabulovski, Araris 🇨🇭 \| ADC Linkers, Replacing Chemotherapy \| E41	Flot.bio x Philip Hemme	68:49
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 \| Rare Diseases, Small Molecules \| E40	Flot.bio x Philip Hemme	78:34
Alex Zhavoronkov, Insilico Medicine \| AI Drug Development, Longevity \| E39	Flot.bio x Philip Hemme	58:02
Robin Carr, Myricx Bio 🇬🇧 \| New ADC Payloads, London Biotech Startups \| E38	Flot.bio x Philip Hemme	58:22
Aino Kalervo, TILT Biotherapeutics 🇫🇮 \| Immunotherapy, Oncolytic Virus \| E37 [Sponsored]	Flot.bio x Philip Hemme	49:17
Renee Aguiar-Lucander, Hansa Biopharma 🇸🇪 \| Immunology, Gene therapy \| E36	Flot.bio x Philip Hemme	53:46
Stephane Bancel, Moderna \| mRNA Therapeutics, Boston Biotech Mafia, AI Biotech \| E35	Flot.bio x Philip Hemme	58:51
Chris Martin, Verona Pharma 🇬🇧 \| Ohtuvayre, COPD, Execution \| E34	Flot.bio x Philip Hemme	55:24
Daniela Marino, CUTISS 🇨🇭 \| Skin Tissue Therapeutics, TechBio \| E33 [Sponsored]	Flot.bio x Philip Hemme	66:13
Joris Pezzini, Alira Health \| Hottest Biotech Insights \| E32 [Sponsored]	Flot.bio x Philip Hemme	70:41
Christophe Bourdon, LEO Pharma 🇩🇰 \| Biopharma Turnaround \| E31	Flot.bio x Philip Hemme	50:47
Christoph Broja, EQT 🇩🇪🇳🇱 \| #1 European Biotech VC, LSP Marriage, ADCs \| E30	Flot.bio x Philip Hemme	62:10
Philipp Baaske, NanoTemper 🇩🇪 \| Bootstrapping in Biotech \| E29 [Sponsored]	Flot.bio x Philip Hemme	71:11
Mathias Uhlen 🇸🇪 \| Entrepreneurial Scientist, 26 times \| E28	Flot.bio x Philip Hemme	49:25
Thomas Ybert, DNA Script 🇫🇷 \| DNA Printing & Synthesis \| E27	Flot.bio x Philip Hemme	58:36
Gunilla Osswald, BioArctic 🇸🇪 \| Leqembi, Alzheimer’s disease \| E26	Flot.bio x Philip Hemme	54:25
Sean Marett 🇩🇪 \| BioNTech, Art of Dealmaking \| E25	Flot.bio x Philip Hemme	74:55
Lovisa Afzelius, Flagship Pioneering 🇸🇪 \| Company building, AI \| E24	Flot.bio x Philip Hemme	59:16
Szabolcs Nagy, Turbine 🇭🇺 \| AI in Biotech, Simulation \| E23 [Sponsored]	Flot.bio x Philip Hemme	64:44
Adrian Rawcliffe, Adaptimmune 🇬🇧 \| Tecelra, TCR Cell Therapy, Solid Tumors \| E22	Flot.bio x Philip Hemme	54:29

Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61

Flot.bio x Philip Hemme

74:40

ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech | Pierre d’Epenoux | E60

Flot.bio x Philip Hemme

47:24

CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River | E59 [Sponsored]

Flot.bio x Philip Hemme

61:30

Ex-CEO of Incyte Hervé Hoppenot on 10x Growth, Biotech Cycles, and Breaking Bureaucracy | E58

Flot.bio x Philip Hemme

58:35